These models have demonstrated that blocking the murine PD-1/PD-L1 axis can result in immune-mediated anti-tumor activity and in a number of cases cooperativity and/or synergy with other T cell modulating agents [21–23]. This evidence concerns the gene CD274 and neoplasm.